EPIQ Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.35M Buy
15,662
+4,509
+40% +$397K 0.58% 41
2026
Q2
$872K Sell
11,153
-100
-0.9% -$8.07K 0.37% 46
2026
Q1
$975K Hold
11,253
– – 0.46% 46
2025
Q4
$1.08M Hold
11,253
– – 0.5% 45
2025
Q3
$1.07M Hold
11,253
– – 0.51% 42
2025
Q2
$981K Sell
11,253
-1,000
-8% -$84.8K 0.5% 43
2025
Q1
$1.1M Hold
12,253
– – 0.58% 41
2024
Q4
$979K Sell
12,253
-1,200
-9% -$104K 0.53% 42
2024
Q3
$1.21M Hold
13,453
– – 0.67% 35
2024
Q2
$1.06M Hold
13,453
– – 0.72% 35
2024
Q1
$1.17M Hold
13,453
– – 0.78% 35
2023
Q4
$1.11M Sell
13,453
-4,700
-26% -$358K 0.79% 35
2023
Q3
$1.42M Hold
18,153
– – 1.07% 30
2023
Q2
$1.6M Buy
18,153
+300
+2% +$25.8K 1.09% 32
2023
Q1
$1.44M Sell
17,853
-956
-5% -$77.9K 0.99% 34
2022
Q4
$1.46M Sell
18,809
-300
-2% -$24.3K 0.97% 36
2022
Q3
$1.54M Buy
19,109
+1,283
+7% +$115K 0.95% 39
2022
Q2
$1.6M Sell
17,826
-24
-0.1% -$2.43K 0.98% 39
2022
Q1
$1.98M Sell
17,850
-868
-5% -$91.7K 1.06% 37
2021
Q4
$1.94M Sell
18,718
-200
-1% -$23.2K 1.03% 37
2021
Q3
$2.37M Buy
18,918
+3,717
+24% +$481K 1.09% 37
2021
Q2
$1.89M Buy
15,201
+24
+0.2% +$3.01K 0.95% 38
2021
Q1
$1.79M Sell
15,177
-208
-1% -$24.4K 1.03% 38
2020
Q4
$1.8M Hold
15,385
– – 1.25% 32
2020
Q3
$1.68M Sell
15,385
-300
-2% -$30.1K 1.27% 33
2020
Q2
$1.44M Hold
15,685
– – 1.31% 31
2020
Q1
$1.41M Buy
15,685
+208
+1% +$22.1K 1.56% 28
2019
Q4
$1.76M Buy
+15,477
New +$1.7M 1.78% 26

Other funds holding MDT

EPIQ Partners's MDT Position: Q3 2026 in Review

EPIQ Partners increased its Medtronic (MDT) stake by 40% in Q3 2026, buying an estimated $397K and bringing the position to 15,662 shares worth $1.35M. The position accounts for 0.58% of the portfolio, ranked #41.

EPIQ Partners first reported a position in MDT in Q4 2019 and has held it in 28 quarters since. The position peaked at $2.37M in Q3 2021. 478 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • EPIQ Partners held 15,662 shares of Medtronic worth $1.35M as of Q3 2026.
  • EPIQ Partners bought 4,509 Medtronic shares in Q3 2026, an estimated $397K.
  • Medtronic made up 0.58% of EPIQ Partners's portfolio in Q3 2026, its #41 holding.
  • EPIQ Partners first reported a position in Medtronic in Q4 2019 and has held it in 28 quarters since.
  • EPIQ Partners's Medtronic position peaked at $2.37M in Q3 2021.
  • 478 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on EPIQ Partners's 13F filing for Q3 2026, filed 7 Oct 2026.